Endothelial activation, lymphangiogenesis, and humoral rejection of kidney transplants

Human Pathology

Volumn 51, Issue , 2016, Pages 86-95

  Phillips, Sharon ^a   Kapp, Meghan ^a   Crowe, Deborah ^b   Garces, Jorge ^c   Fogo, Agnes B ^a   Giannico, Giovanna A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b DCI Transplant Immunology Laboratory   (United States)

^c Ochsner Transplant Center   (United States)

Author keywords

Endothelial activation; Humoral rejection; Kidney transplant; Microvascular injury; Selectin; Transplant biopsy

Indexed keywords

COMPLEMENT COMPONENT C4D; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; COMPLEMENT COMPONENT C4B;

ADULT; ARTICLE; ATROPHY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULOPATHY; GRAFT FAILURE; HELPER CELL; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; INFLAMMATORY INFILTRATE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; REGULATORY T LYMPHOCYTE; TUBULAR ATROPHY; ENDOTHELIUM CELL; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY;

ADULT; COMPLEMENT C4B; ENDOTHELIAL CELLS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; LYMPHANGIOGENESIS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84960193486     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2015.12.020     Document Type: Article

References (33)

1. J. Sellares, D.G. de Freitas, M. Mengel, and et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence Am J Transplant 12 2012 388 399
2. R.S. Gaston, J.M. Cecka, B.L. Kasiske, and et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure Transplantation 90 2010 68 74
3. X. Zhang, and E.F. Reed Effect of antibodies on endothelium Am J Transplant 9 2009 2459 2465
4. T. Hirohashi, C.M. Chase, P. Della Pelle, and et al. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody Am J Transplant 12 2012 313 321
5. H.E. Feucht, H. Schneeberger, G. Hillebrand, and et al. Capillary deposition of C4d complement fragment and early renal graft loss Kidney Int 43 1993 1333 1338
6. D. Cohen, R.B. Colvin, M.R. Daha, and et al. Pros and cons for C4d as a biomarker Kidney Int 81 2012 628 639
7. J. Sellares, J. Reeve, A. Loupy, and et al. Molecular diagnosis of antibody-mediated rejection in human kidney transplants Am J Transplant 13 2013 971 983
8. B. Sis, G.S. Jhangri, S. Bunnag, and et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining Am J Transplant 9 2009 2312 2323
9. S. Stuht, W. Gwinner, I. Franz, and et al. Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies Am J Transplant 7 2007 377 384
10. T. Dietrich, F. Bock, D. Yuen, and et al. Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation J Immunol 184 2010 535 539
11. N. Yin, N. Zhang, J. Xu, and et al. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival Transplantation 92 2011 25 30
12. S.M. Bonsib Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases Mod Pathol 19 2006 746 753
13. R.B. Colvin, A.H. Cohen, C. Saiontz, and et al. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation J Am Soc Nephrol 8 1997 1930 1941
14. K. Solez, R.B. Colvin, L.C. Racusen, and et al. Banff 07 classification of renal allograft pathology: updates and future directions Am J Transplant 8 2008 753 760
15. M. Haas, B. Sis, L.C. Racusen, and et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions Am J Transplant 14 2014 272 283
16. M. Hourmant, A. Cesbron-Gautier, P.I. Terasaki, and et al. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation J Am Soc Nephrol 16 2005 2804 2812
17. M.L. Rose Endothelial cells as antigen-presenting cells: role in human transplant rejection Cell Mol Life Sci 54 1998 965 978
18. K. Trpkov, P. Campbell, F. Pazderka, and et al. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Analysis using the Banff grading schema Transplantation 61 1996 1586 1592
19. R.B. Colvin Antibody-mediated renal allograft rejection: diagnosis and pathogenesis J Am Soc Nephrol 18 2007 1046 1056
20. P.K. Koskinen, and K.B. Lemstrom Adhesion molecule P-selectin and vascular cell adhesion molecule-1 in enhanced heart allograft arteriosclerosis in the rat Circulation 95 1997 191 196
21. A. Izawa, T. Ueno, M. Jurewicz, and et al. Importance of donor- and recipient-derived selectins in cardiac allograft rejection J Am Soc Nephrol 18 2007 2929 2936
22. B. Sarraj, J. Ye, A.I. Akl, and et al. Impaired selectin-dependent leukocyte recruitment induces T-cell exhaustion and prevents chronic allograft vasculopathy and rejection Proc Natl Acad Sci U S A 111 2014 12145 12150
23. R. Langer, M. Wang, S.M. Stepkowski, and et al. Selectin inhibitor bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines J Am Soc Nephrol 15 2004 2893 2901
24. E. Bettelli, Y. Carrier, W. Gao, and et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 2006 235 238
25. L. Xu, A. Kitani, I. Fuss, and et al. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta J Immunol 178 2007 6725 6729
26. C.O. Savage, C.C. Hughes, R.B. Pepinsky, and et al. Endothelial cell lymphocyte function-associated antigen-3 and an unidentified ligand act in concert to provide costimulation to human peripheral blood CD4+ T cells Cell Immunol 137 1991 150 163
27. P.W. Adams, H.S. Lee, W.J. Waldman, and et al. Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells J Immunol 148 1992 3753 3760
28. C. Page, C. Thompson, M. Yacoub, and et al. Human endothelial stimulation of allogeneic T cells via a CTLA-4 independent pathway Transpl Immunol 2 1994 342 347
29. K. Murakami, W. Ma, R. Fuleihan, and et al. Human endothelial cells augment early CD40 ligand expression in activated CD4+ T cells through LFA-3-mediated stabilization of mRNA J Immunol 163 1999 2667 2673
30. C. Taflin, B. Favier, J. Baudhuin, and et al. Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions Proc Natl Acad Sci U S A 108 2011 2891 2896
31. J.J. Kim, R. Balasubramanian, G. Michaelides, and et al. The clinical spectrum of de novo donor-specific antibodies in pediatric renal transplant recipients Am J Transplant 14 2014 2350 2358
32. I. Batal, J.G. Lunz III, N. Aggarwal, and et al. A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies Am J Transplant 10 2010 2442 2452
33. P. Randhawa T-cell-mediated rejection of the kidney in the era of donor-specific antibodies: diagnostic challenges and clinical significance Curr Opin Organ Transplant 20 2015 325 332